The invention is directed to concentrating autologously-derived plasma, using the concentrated plasma fluid to dilute the patients cells and applying the combination of concentrated fluid with cells at a site of pathology or mixing the combination of concentrated fluid with cells with a particulate material like a bone void filler prior to placing the mixture at a site of pathology.
